Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-09-23

FDA Approved: GLYBURIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for glyburide from Teva Pharmaceuticals USA, Inc. The approval indicates changes to an already approved product (such as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glyburide (glyburide)

Snippet

SUPPL AP for GLYBURIDE (GLYBURIDE)